These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17906679)

  • 1. Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists.
    Lunn CA; Reich EP; Fine JS; Lavey B; Kozlowski JA; Hipkin RW; Lundell DJ; Bober L
    Br J Pharmacol; 2008 Jan; 153(2):226-39. PubMed ID: 17906679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid CB(2)-selective inverse agonist protects against antigen-induced bone loss.
    Lunn CA; Fine J; Rojas-Triana A; Jackson JV; Lavey B; Kozlowski JA; Hipkin RW; Lundell DJ; Bober L
    Immunopharmacol Immunotoxicol; 2007; 29(3-4):387-401. PubMed ID: 18075852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triaryl bis-sulfones as a new class of cannabinoid CB2 receptor inhibitors: identification of a lead and initial SAR studies.
    Lavey BJ; Kozlowski JA; Hipkin RW; Gonsiorek W; Lundell DJ; Piwinski JJ; Narula S; Lunn CA
    Bioorg Med Chem Lett; 2005 Feb; 15(3):783-6. PubMed ID: 15664857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo.
    Lunn CA; Fine JS; Rojas-Triana A; Jackson JV; Fan X; Kung TT; Gonsiorek W; Schwarz MA; Lavey B; Kozlowski JA; Narula SK; Lundell DJ; Hipkin RW; Bober LA
    J Pharmacol Exp Ther; 2006 Feb; 316(2):780-8. PubMed ID: 16258021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of triaryl bis-sulfones as cannabinoid-2 receptor ligands.
    Lavey BJ; Kozlowski JA; Shankar BB; Spitler JM; Zhou G; Yang DY; Shu Y; Wong MK; Wong SC; Shih NY; Wu J; McCombie SW; Rizvi R; Wolin RL; Lunn CA
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3760-4. PubMed ID: 17466519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of SAR studies on triaryl bis sulfone cannabinoid CB2 receptor ligands.
    Tong L; Shankar BB; Chen L; Rizvi R; Kelly J; Gilbert E; Huang C; Yang DY; Kozlowski JA; Shih NY; Gonsiorek W; Hipkin RW; Malikzay A; Lunn CA; Lundell DJ
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6785-9. PubMed ID: 20850969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updating the chemistry and biology of cannabinoid CB2 receptor-specific inverse agonists.
    Lunn CA
    Curr Top Med Chem; 2010; 10(8):768-78. PubMed ID: 20370714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders.
    Sipe JC; Arbour N; Gerber A; Beutler E
    J Leukoc Biol; 2005 Jul; 78(1):231-8. PubMed ID: 15845647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triaryl bis-sulfones as cannabinoid-2 receptor ligands: SAR studies.
    Shankar BB; Lavey BJ; Zhou G; Spitler JA; Tong L; Rizvi R; Yang DY; Wolin R; Kozlowski JA; Shih NY; Wu J; Hipkin RW; Gonsiorek W; Lunn CA
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4417-20. PubMed ID: 16115769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-aromatic A-ring replacement in the triaryl bis-sulfone CB2 receptor inhibitors.
    Gilbert EJ; Zhou G; Wong MK; Tong L; Shankar BB; Huang C; Kelly J; Lavey BJ; McCombie SW; Chen L; Rizvi R; Dong Y; Shu Y; Kozlowski JA; Shih NY; Hipkin RW; Gonsiorek W; Malikzay A; Lunn CA; Favreau L; Lundell DJ
    Bioorg Med Chem Lett; 2010 Jan; 20(2):608-11. PubMed ID: 20005710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models.
    Yao BB; Hsieh GC; Frost JM; Fan Y; Garrison TR; Daza AV; Grayson GK; Zhu CZ; Pai M; Chandran P; Salyers AK; Wensink EJ; Honore P; Sullivan JP; Dart MJ; Meyer MD
    Br J Pharmacol; 2008 Jan; 153(2):390-401. PubMed ID: 17994110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the CB2 receptor for immune modulation.
    Lunn CA; Reich EP; Bober L
    Expert Opin Ther Targets; 2006 Oct; 10(5):653-63. PubMed ID: 16981823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
    Ashton JC; Wright JL; McPartland JM; Tyndall JD
    Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of (3',5'-dichloro-2,6-dihydroxy-biphenyl-4-yl)-aryl/alkyl-methanone selective CB2 inverse agonist.
    Presley CS; Mustafa SM; Abidi AH; Moore BM
    Bioorg Med Chem; 2015 Sep; 23(17):5390-401. PubMed ID: 26275680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis.
    Shi Y; Duan YH; Ji YY; Wang ZL; Wu YR; Gunosewoyo H; Xie XY; Chen JZ; Yang F; Li J; Tang J; Xie X; Yu LF
    J Med Chem; 2017 Aug; 60(16):7067-7083. PubMed ID: 28726401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists.
    Whiteside GT; Lee GP; Valenzano KJ
    Curr Med Chem; 2007; 14(8):917-36. PubMed ID: 17430144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CB2 cannabinoid receptor agonist selectively inhibits the mechanosensitivity of mucosal afferents in the guinea pig bladder.
    Christie S; Zagorodnyuk V
    Am J Physiol Renal Physiol; 2021 May; 320(5):F859-F865. PubMed ID: 33749323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cannabinoid CB
    Salort G; Álvaro-Bartolomé M; García-Sevilla JA
    Psychopharmacology (Berl); 2017 Mar; 234(6):925-941. PubMed ID: 28127623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.